A Safety Evaluation of Personal Lubricant Product When Used by Couples in Home-use Conditions
NCT ID: NCT00779025
Last Updated: 2011-10-07
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
82 participants
INTERVENTIONAL
2008-01-31
2008-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
YOURS and MINE
Male Personal Lubricant (10855-096) used in conjunction with Female Personal Lubricant (PD-F-5254)
PD-F-5254
Female Personal Lubricant (MINE)
10855-096
Male Personal Lubricant (YOURS)
MINE Alone
Female Personal Lubricant (PD-F-5254)
PD-F-5254
Female Personal Lubricant (MINE)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PD-F-5254
Female Personal Lubricant (MINE)
10855-096
Male Personal Lubricant (YOURS)
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* In committed heterosexual relationship for \>6months
* On acceptable method of birth control
Exclusion Criteria
* Allergy to product ingredients
* Irritation or infection in genital area
* Unstable or uncontrolled medical condition
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johnson & Johnson Consumer and Personal Products Worldwide
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rita Wanser
Role: STUDY_DIRECTOR
J&J CPPW
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Concentrics Center for Research
Indianapolis, Indiana, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CA-P-6020-1
Identifier Type: -
Identifier Source: org_study_id